[1]杨彩红a,萧韵健a,袁 飞a,等.原发性舍格伦综合征患者血清ADAM17 表达水平及其与病情程度的相关性研究[J].现代检验医学杂志,2023,38(06):131-135+190.[doi:10.3969/j.issn.1671-7414.2023.06.024]
　YANG Caihonga,XIAO Yunjiana,YUAN Feia,et al.Study on the Expression Level of Serum ADAM17 in Patients with Primary Sjogren’s Syndrome and Its Correlation with the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2023,38(06):131-135+190.[doi:10.3969/j.issn.1671-7414.2023.06.024]
点击复制

原发性舍格伦综合征患者血清ADAM17 表达水平及其与病情程度的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年06期
页码:
131-135+190
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Study on the Expression Level of Serum ADAM17 in Patients with Primary Sjogren’s Syndrome and Its Correlation with the Severity of the Disease
文章编号:
1671-7414（2023）06-131-06
作者:
杨彩红a; 萧韵健a; 袁 飞a;  莫伟平b
（东莞市人民医院a. 风湿科；b. 检验科，广东东莞 523126）
Author(s):
YANG Caihonga; XIAO Yunjiana; YUAN Feia; MO Weipingb
（a. Department of Rheumatology；b. Department of Clinical Laboratory, Dongguan People’s Hospital， Guangdong Dongguan 523126, China）
关键词:
原发性舍格伦综合征; 解聚素金属蛋白酶17; 免疫功能
分类号:
R593.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.06.024
文献标志码:
A
摘要:
目的 探究原发性舍格伦综合征（primary Sjogren syndrome，PSS）患者中血清解聚素金属蛋白酶17（adisintegrin and metalloprotease 17，ADAM17）表达水平及其与病情程度的关系。方法 选取东莞市人民医院风湿科在2022 年2 月1 日～ 10 月1 日收治的86 例PSS 患者（PSS 组），分活动期组和稳定期组，选取同期健康体检者43 例作为对照组。采用酶联免疫吸附法（enzyme-linked immumosorbent assay, ELISA）检测血清ADAM17 水平；采用免疫双扩散法检测血清抗SSA 抗体和抗SSB 抗体；采用流式细胞法检测血清炎症因子；采用Logistic 回归分析PSS 的影响因素；采用Pearson 法分析血清ADAM17 与PSS 患者生化指标的相关性；采用spearman 分析血清ADAM17 与舍格伦综合征疾病活动指数（Sjogren's syndrome disease activity index，SSDAI）评分的相关性；采用多元线性回归分析影响SSDAI评分的因素。结果 稳定期组和活动期组抗SSA 抗体阳性率、抗SSB 抗体阳性率、肿瘤坏死因子-α（tumor necrosisfactor-α，TNF-α）、白细胞介素-6（interleukin-6，IL-6）、白细胞介素-17（interleukin-17，IL-17）和ADAM17 表达水平均高于对照组，白细胞介素-10（interleukin-10; IL-10）表达水平低于对照组，差异均有统计学意义（χ2=4.288~53.030，t=4.860~33.081，均P ＜ 0.05）；PSS 患者活动期组抗SSA 抗体阳性率、抗SSB 抗体阳性率、TNF-α，IL-6，IL-17，ADAM17 和SSDAI 评分高于稳定期组，IL-10 表达水平低于稳定期组，差异均有统计学意义（χ2=11.764，13.936，t=8.186，4.862，13.295，5.108，9.846，均P ＜ 0.05）；Logistic 多因素回归分析表明，高水平ADAM17，抗SSA 抗体阳性、抗SSB抗体阳性、高水平TNF-α，高水平IL-6，低水平IL-10 和高水平IL-17 是影响PSS 发生的危险因素（P＜ 0.05）；根据Pearson 相关性分析得知，PSS 患者血清ADAM17 水平与TNF-α，IL-6，IL-17 水平呈正相关（r=0.543，0.582，0.578，均P ＜ 0.05），与IL-10 水平呈负相关（r=-0.572，P ＜ 0.05）；根据spearman 相关性分析得知，血清ADAM17 水平与SSDAI 评分呈正相关（r=0.603，P ＜ 0.05）。多元线性回归分析结果表明，高水平ADAM17，抗SSA 抗体阳性、抗SSB 抗体阳性、高水平TNF-α，高水平IL-6，低水平IL-10 和高水平IL-17 是影响SSDAI 评分的危险因素（P ＜ 0.05）。结论 PSS 患者血清ADAM17水平显著升高，其与患者的病情严重程度相关，其表达水平随着病情严重程度增加而增加。
Abstract:
Objective To investigate the expression level of serum a disintegrin and metalloprotease domain-17 (ADAM17) in patients with Primary Sjogren syndrome (PSS) and its relationship with the degree of disease. Methods A total of 86 PSS patients (PSS group) admitted by the Department of Rhumatology of Dongguan People’s Hospital from February 1,2022 to October 1, 2022 were divided into active and stable groups, and 43 healthy physicalexaminers during the same period were selected as the control group. Serum adam17 level was detected by enzyme-linked immunosorbent assay. Serum anti-SSA antibody and anti-SSB antibody were detected by immunodcuble diffusion method. Flow cytometry was used to detect serum inflammatory factors. Logistic regression was used to analyze the influencing factors of PSS. Pearson method was used to analyze the correlatiion between serum ADAM17 and biochemical indexes of PSS patients. Spearman was used to analyze the correlation between serum ADAM17 and Sjogren’s syndrome disease activity index (SSDAI) score. And multivariate linear regression was used to analyze the factors influencing the SSDAI score. Results SSA antibody positivity rates, SSB antibody positivity rates, tumor necrosis factor-α(TNF-α), interleukin-6(IL-6), interleukin-17(IL-17), ADAM1 and in stable group and active groups expression level were higher than that of control group, but interleukin-10 expression level was lower than that of control group, and the differences were statistically significant(χ2=4.288~53.030; t=4.860~33.081，all P<0.05). Positive rates of anti-SSA antibody, anti-SSB antibodies, and TNF-α in the active phase group of PSS patients-α, IL-6, IL-17, ADAM17 and SSDAI scores were higher in the stable phase group, while IL-10 epression levels were lower in the stable phase group, and the differences were statistically significant(χ2=11.764, 13.936; t=8.186, 4.862, 13.295, 5.108, 9.846, all P<0.05). Logistic regression analysis showed that high level of ADAM17, positive anti-SSA antibody, positive anti-SSB antibody, high level of TNF-α, high level of IL-6, low level of IL-10, and high level of IL-17 were risk factors for PSS (all P<0.05). According to Pearson correlation analysis, the level of serum ADAM17 in PSS patients was positively correlated with TNF-α, IL-6, IL-17 levels (r=0.543, 0.582, 0.578, all P<0.05), and negatively correlated with IL-10 level (r=-0.572, P<0.05). According to spearman correlation analysis, serum ADAM17 levels were positively correlated with SSDAI scores (r=0.603, P<0.05).The results of multiple linear regression analysis showed that high level of ADAM17, positive anti-SSA antibody, positive anti-SSB antibody, high level of TNF-α, high level of IL-6, low level of IL-10, and high level of IL-10 were the risk factors affecting the SSDAI score (all P<0.05). Conclusion Serum ADAM17 levels in patients with PSS are significantly elevated, which correlated with the severity of the patient’s condition, and its expression level increases with increasing severity.

参考文献/References:

[1] 岳晓琳, 米晓燕, 白圆圆, 等. 原发性舍格伦综合征患者血浆弗林蛋白酶和Th1 型细胞因子水平表达与唇腺损害及相关腺体功能的关系研究[J]. 现代检验医学杂志, 2021, 36(4): 10-14, 50. YUE Xiaolin, MI Xiaoyan, BAI Yuanyuan, et al. Relationship between plasma FURIN and Th1 type cytokines level, labial gland damage and related glandular function in patients with primary Sjogren’s syndrome[J]. Journal of Modern Laboratory Medicine,2021, 36(4): 10-14, 50.
[2] SEROR R, NOCTURNE G, MARIETTE X. Current and future therapies for primary Sj?gren syndrome[J].Nature Reviews Rheumatology, 2021, 17(8): 475-486.
[3] KAPSOGEORGOU E K, TZIOUFAS A G. Interaction of human salivary gland epithelial cells with B lymphocytes: implications in the pathogenesis of Sj?gren’s syndrome [J]. Mediterr J Rheumatol, 2020,31(4): 424-426.
[4] YANG Guang, CUI Mengying, JIANG Weibo, et al. Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17[J]. Aging (Albany NY),2021, 13(12): 16859-16872.
[5] SISTO M, LISI S, D’AMORE M, et al. The metalloproteinase Adam17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sj?gren’s syndrome[J]. Clinical and Experimental Medicine, 2015, 15(2): 215-225.
[6] 赵韵琦, 李晓悦, 江超, 等. 原发性干燥综合征患者血清25 羟基维生素D3 的表达及临床意义[J]. 临床医学研究与实践, 2020, 5(6): 118-119, 124. ZHAO Yunqi, LI Xiaoyue, JIANG Chao, et al. Expression of serum 25-hydroxyvitamin D3 in patients with primary Sjogren’s syndrome and its clinical significance [J]. Clinical Research and Practice, 2020,5(6): 118-119, 124.
[7] 张文, 厉小梅, 徐东, 等. 原发性干燥综合征诊疗规范[J]. 中华内科杂志, 2020, 59(4): 269-276. ZHANG Wen, LI Xiaomei, XU Dong, et al. Recommendations of diagnosis and treatment of primary Sjogren’s syndrome in China[J]. Chinese Journal of Internal Medicine, 2020, 59(4): 269-276.
[8] CHEN Weiqian, YANG Fan, XU Guanhua, et al. Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sj?gren’s syndrome[J]. Journal of Leukocyte Biology, 2021,109(2): 437-447.
[9] 朱丽娟, 张振山, 夏楠楠, 等. 老年原发性干燥综合征患者血清miR-146a 和miR-155 表达及临床意义[J]. 中国老年学杂志, 2019, 39(20): 5020-5024. ZHU Lijuan, ZHANG Zhenshan, XIA Nannan, et al. Expressions and clinical significances of serum miR-146 a and miR-155 in elderly patients with primary Sjogren’s syndrome[J]. Chinese Journal of Gerontology, 2019, 39(20): 5020-5024.
[10] YANG Xiaoxiao, YANG Chao, WANG Li, et al. Molecular mechanism of sphingosine-1-phosphate receptor 1 regulating CD4+ tissue memory in situ T cells in primary Sjogren’s syndrome [J]. Int J Gen Med,2021, 14:6177-6188.
[11] FENG Zhe, ZHANG Biqing, ZHU Yamei, et al. The effectiveness and safety of total glucosides of pacony in primary Sjogren’s syndrome:a systematic review and metaanalysis[J]. Frontiers in Pharmacology, 2019, 10: 550.
[12] 成雅, 王海芳, 袁瑞华, 等. ADAM17 与心血管疾病的相关性研究进展[J]. 心脏杂志, 2021, 33(2): 199-204. CHENG Ya, WANG Haifang, YUAN Ruihua, et al. Research advance in correlation between a disintegrin and metallopro-teinase 17 (Adam17) and cardiovascular diseases[J]. Chinese Heart Journal, 2021, 33(2): 199-204.
[13] KAWAI T, ELLIOTT K J, SCALIA R, et al. Contribution of ADAM17 and related ADAMs in cardiovascular diseases[J]. CMLS-Cellular and Molecular Life Sciences, 2021, 78(9): 4161-4187.
[14] ROGMANS C, KUHLMANN J D, HUGENDIECK G, et al. ADAM17-a potential blood-based biomarker for detection of early-stage ovarian cancer[J]. Cancers,2021, 13(21): 5563.
[15] 张敏, 冯怡锟, 张岩, 等. 结直肠腺癌组织中MMP2,ADAM17 及E-cadherin 的表达及临床意义[J]. 癌症进展, 2020, 18(4): 414-417. ZHANG Min, FENG Yikun, ZHANG Yan, et al. Expression and clinical significance of MMP2,ADAM17 and E-cadherin in colorectal adenocarcinoma tissues[J]. Oncology Progress, 2020, 18(4): 414-417.
[16] WANG Xiaoyan, XIN Shaojun, WANG Youqing,et al. MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary Sj?gren’s syndrome[J]. Bioengineered, 2021, 12(1): 310-324.
[17] CAFARO G, PERRICONE C, BALDINI C, et al. Significance of anti-La/SSB antibodies in primary Sj?gren’s syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy[J]. Clinical and Experimental Rheumatology, 2020, 38 Suppl 126(4): 53-56.
[18] YANG Hongjun. Cytokine expression in patients with interstitial lung disease in primary Sjogren’s syndrome and its clinical significance[J]. American Journal of Translational Research, 2021, 13(7): 8391-8396.
[19] 徐榕, 康海锋, 刘宏斌, 等. 去整合素- 金属蛋白酶17 在消化系统恶性肿瘤中的研究现状[J]. 世界华人消化杂志, 2020, 28(19): 986-991. XU Rong, KANG Haifeng, LIU Hongbin, et al. Role of a disintegrin and metalloproteinase 17 in malignant tumors of the digestive system[J]. World Chinese Journal of Digestology, 2020, 28(19): 986-991.
[20] 蒋芳艳, 苏海庆, 周琛, 等. 原发性干燥综合征关节炎肌骨超声半定量评分与疾病活动指数的相关性分析[J]. 广西医科大学学报, 2018, 35(4): 491-493. JIANG Fangyan, SU Haiqing, ZHOU Chen, et al. Correlation between the ultrasonic scoring system of arthritis and the assessment of disease activity in primary Sjogren’s syndrome[J]. Journal of Guangxi Medical University, 2018, 35(4): 491-493.

相似文献/References:

[1]俞 静,朱群英,陈 燕.原发性舍格伦综合征患者外周血Th22细胞水平的变化及其临床意义[J].现代检验医学杂志,2016,31(05):69.[doi:10.3969/j.issn.1671-7414.2016.05.018]
　YU Jing,ZHU Qun-ying,CHEN Yan.Change of Th22 Cells in Peripheral Blood of Patients with Primary Sjogren's Syndrome and Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(06):69.[doi:10.3969/j.issn.1671-7414.2016.05.018]
[2]岳晓琳,米晓燕,白圆圆,等.原发性舍格伦综合征患者血浆弗林蛋白酶和Th1型细胞因子水平表达与唇腺损害及相关腺体功能的关系研究[J].现代检验医学杂志,2021,36(04):10.[doi:10.3969/j.issn.1671-7414.2021.04.003]
　YUE Xiao-lin,MI Xiao-yan,Bai Yuan-yuan,et al.Relationship between Plasma FURIN and Th1 Type Cytokines Level, LabialGland Damage and Related Glandular Function in Patients with PrimarySjogren’s Syndrome[J].Journal of Modern Laboratory Medicine,2021,36(06):10.[doi:10.3969/j.issn.1671-7414.2021.04.003]
[3]石 娴,傅曼妮,解翠林.原发性舍格伦综合征患者血清miR-193b 表达水平及其临床价值研究[J].现代检验医学杂志,2023,38(04):126.[doi:10.3969/j.issn.1671-7414.2023.04.023]
　SHI Xian,FU Manni,XIE Cuilin.Study on the Expression Level of miR-193b in Serum and Its Clinical Value in Patients with Primary Sjogren’s Syndrome[J].Journal of Modern Laboratory Medicine,2023,38(06):126.[doi:10.3969/j.issn.1671-7414.2023.04.023]
[4]邓正鑫a,刘惠杰b,冯长州a,等.原发性舍格伦综合征患者血清MPO-DNA 水平与疾病活动度的相关性研究[J].现代检验医学杂志,2024,39(05):102.[doi:10.3969/j.issn.1671-7414.2024.05.019]
　DENG Zhengxina,LIU huijieb,FENG Changzhoua,et al.Study on the Correlation between Serum MPO-DNA Levels and Disease Activity in Patients with Primary Sj?gren’s Syndrome[J].Journal of Modern Laboratory Medicine,2024,39(06):102.[doi:10.3969/j.issn.1671-7414.2024.05.019]

备注/Memo

备注/Memo:
基金项目： 东莞市社会发展科技项目（项目编号：20211800902992)：抗毒蕈碱3 受体（M3R）抗体在原发性干燥综合征诊断价值及发病机制的探讨。
作者简介：杨彩红（1983-），女，研究生，主治医师，研究方向：风湿免疫学，E-mail：yfjwh71@163.com。
更新日期/Last Update: 2023-11-15